Original Press Release
EDDA Technology Launches IQQA®-Chest Enterprise CAD Solution for Digital X-Ray
Press release date: November 17, 2006
PRINCETON JUNCTION, N.J., Nov. 17 -- EDDA Technology today announced the commercial release of IQQA®-Chest software V2.0 featuring enterprise CAD solution for digital X-ray. IQQA®-Chest is the only FDA cleared system to offer real-time interactive diagnostic analysis of digital chest X-rays using a comprehensive set of tools to support radiologists in their identification, confirmation and quantification of lung nodules. IQQA®-Chest has clinically demonstrated an ability to improve radiologists' detection of small lung nodules (5-15mm) up to 85 percent.
Powered with the same computer-assisted detection support software of the debut software V1.0, IQQA®-Chest Enterprise aims to redefine how advanced clinical applications can and should be accessed by radiologists. Up to now, radiologists have simply had to accept that the use of advanced imaging software meant they would have to operate at dedicated workstations detached from their primary PACS review stations. Although static image results could often be sent from these stand-alone workstations back to a PACS for review, it was still not possible to enjoy access to the full functionality of these advanced applications at the PACS viewing station.
Responding to this clinical challenge, EDDA has developed a unique enabling solution capable of instantly deploying the full functionality of the IQQA®-Chest application on existing PACS review consoles without additional requirement or setup effort on the workstations.
According to Dr. Edwin van Beek, Professor of Radiology, University of Iowa Hospital and Clinics, the need for this level of performance is particularly critical with chest radiography, the most frequently performed imaging study. University of Iowa Hospital and Clinics, a commercial site of EDDA's, has recently been upgraded to IQQA®-Chest Enterprise.
"With the number of chest X-rays we read on a daily basis, to maximize the benefit from a CAD application will be highly dependent upon the accessibility we have to the full application at our PACS review stations," added Dr. van Beek. "EDDA has cleared this hurdle with IQQA®-Chest Enterprise. The immediacy we now enjoy with this tool allows us to expand our use of the application at the University of Iowa with the prospect of further enhancing our overall detection rate."
Dr. van Beek and his colleagues will report on a clinical study conducted at the University of Iowa in which the software was used in their daily practice since January 2006. The study suggests that the software could help residents detect approximately 20% more small lung nodules. The results have been accepted for presentation at the upcoming RSNA 2006 meeting.
"EDDA's vision of seamlessly integrating our advanced detection analysis technology into the radiologist's softcopy reading environment to improve workflow and support clinical decision-making is now being realized with IQQA®-Chest Enterprise," said Jianzhong Qian, President and CEO of EDDA Technology. "With the survivability of lung cancer tied heavily to early detection, we are pleased to provide an innovative solution that can significantly enhance the board access of our advanced CAD application in physicians' daily clinical practice."
EDDA Technology will feature IQQA®-Chest Enterprise at the upcoming 92nd Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA). RSNA 2006 will also provide the occasion for EDDA to showcase another advanced imaging application, IQQA®-Liver. Using data from a contrasted multiphase CT liver study, IQQA®-Liver provides radiologists with comprehensive tools to review all acquired phases simultaneously with automatic anatomic phase registration. It also provides segmentation and measurement tools for visualizing and analyzing liver lesions and vascular structures to support liver disease diagnosis and preoperative assessment and planning. IQQA®-Liver has clearance from the U.S. Food and Drug Administration (FDA), and Chinese State Food and Drug Administration (SFDA).
About EDDA Technology
EDDA Technology, Inc. is an innovative clinical computer solution provider in diagnostic imaging and analysis. EDDA offers a series of new generation software products to enable early detection of diseases and enhance precision in diagnosis. EDDA's goal is to deliver advanced information analysis technologies that improve clinical workflow and accuracy with broad accessibility. A privately held Delaware corporation, EDDA is headquartered in Princeton Junction, New Jersey, and has a regional office in Shanghai, China. In April 2006, EDDA entered into a strategic partnership with Philips Medical Systems to provide advanced digital radiography solutions to assist in the detection of lung lesions. For further information, please log on to http://www.edda-tech.com/, or contact email@example.com or call 609-936-8282.
EDDA Technology will be exhibiting their IQQA® Family of Products in Booth #3271 in the South Hall of McCormick Place in Chicago, Illinois, at the 92nd Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Nov. 26 - Dec. 1, 2006.
Source: EDDA Technology, Inc.
CONTACT: Xiaolan Zeng EDDA Technology, Inc. +1-609-936-8282 ext. 106
Web site: http://www.edda-tech.com/